2026 NPPES data Cardiovascular Disease Physician NPI 1730260035 M.D
Verify on CMS →

NAIM AL-ADLI, M.D

Cardiovascular Disease Physician in SUGAR LAND, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
964
Medicare Part D claims · 165 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$171.69
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: NAIM AL-ADLI, M.D is a Cardiovascular Disease Physician ([object Object]) practicing in SUGAR LAND, Texas with a Medicare Part D prescribing footprint of 964 claims across 165 beneficiaries — 19% brand-name prescribing . Industry payments of $171.69 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: NAIM AL-ADLI, M.D filed 964 Medicare Part D claims in 2023 across SUGAR LAND, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

NAIM AL-ADLI, M.D practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

NAIM AL-ADLI, M.D at a glance

Quality data not reported

NPI registry status

Active

Issued 10/17/2006

NPI 1730260035

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

964 68% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

Specialty distribution in Texas

How Cardiovascular Disease Physician compares to other specialties among Texas providers

Texas providers

Cardiovascular Disease Physician share within Texas

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Cardiovascular Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Cardiovascular Disease Physician ABMS/AOA estimate

Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAIM AL-ADLI, M.D is a Cardiovascular Disease Physician provider practicing in SUGAR LAND, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D. NPI: 1730260035. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NAIM AL-ADLI, M.D appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D credentials at 13020 DAIRY ASHFORD RD, SUGAR LAND, TX, 77478, with a listed phone of (281) 265-8500. NPI 1730260035 was issued on 10/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AL-ADLI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 964 prescription claims written by this provider, covering 165 Medicare beneficiaries and totaling roughly $203K in drug spend, split 19% brand-name and 81% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13020 DAIRY ASHFORD RD
SUGAR LAND, TX 77478

Provider Details

NPI 1730260035
Specialty Cardiovascular Disease Physician
Credentials M.D
Gender Male
NPI Issued 10/17/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAIM AL-ADLI, M.D. Source: openpaymentsdata.cms.gov.

Total received

$172

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NAIM AL-ADLI, M.D. To verify NAIM AL-ADLI, M.D's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NAIM AL-ADLI, M.D — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 964 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

964
Total Claims
$203K
Total Drug Cost
165
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,471
Total Day Supply
73,865
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$188K
Generic Drug Cost
$15K

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.96
Gender Split
47% female / 53% male
Age Distribution
<65: 16, 65-74: 77, 75-84: 61, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amlodipine Besylate
111
Eliquis
Apixaban
97
Atorvastatin Calcium
82
Metoprolol Tartrate
80
Furosemide
76
Clopidogrel
Clopidogrel Bisulfate
59
Carvedilol
41
Metoprolol Succinate
39
Lisinopril
38
Hydralazine Hcl
33

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How NAIM AL-ADLI, M.D fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

NAIM AL-ADLI, M.D's 964 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as AL-ADLI.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAIM AL-ADLI, M.D's specialty?
NAIM AL-ADLI, M.D specializes in Cardiovascular Disease Physician and practices in SUGAR LAND, Texas. Credentials: M.D.
How much does NAIM AL-ADLI, M.D prescribe under Medicare Part D?
In 2023, NAIM AL-ADLI, M.D wrote 964 Medicare Part D claims totaling $203K in drug costs for 165 beneficiaries.
Where is NAIM AL-ADLI, M.D located?
NAIM AL-ADLI, M.D is located at 13020 DAIRY ASHFORD RD, SUGAR LAND, TX, 77478. Phone: (281) 265-8500.
What is NAIM AL-ADLI, M.D's NPI number?
NAIM AL-ADLI, M.D's National Provider Identifier (NPI) is 1730260035, issued on 10/17/2006.
Does NAIM AL-ADLI, M.D prescribe more brand-name or generic drugs?
NAIM AL-ADLI, M.D's prescribing is 19% brand-name and 81% generic drugs by claim count, with $188K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does NAIM AL-ADLI, M.D prescribe most often?
Based on 2023 Medicare Part D data, NAIM AL-ADLI, M.D's most frequently prescribed drugs include Amlodipine Besylate, Eliquis, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAIM AL-ADLI, M.D accept Medicare?
NAIM AL-ADLI, M.D appears in CMS Medicare data with 964 Part D claims and 165 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAIM AL-ADLI, M.D's credentials?
NAIM AL-ADLI, M.D's NPI is 1730260035 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology